Benzinga's Top Pre-Market Losers
December 04, 2012 at 08:20 AM EST
Geron (NASDAQ: GERN ) shares dropped 18.92% to $1.20 in pre-market trading. Geron announced its plans to end development of GRN1005, an experimental brain cancer drug. It also announced its plans to cut 43 jobs Vail Resorts (NYSE: MTN ) shares fell 7.79% to $51.49 in the pre-market trading.
